Inhibitors | Comment | Organism | Structure |
---|---|---|---|
BTB13069 | i.e. 5-methyl-2,4-diphenyl-1,2,3,4,5,6-hexahydrobenzo[b]pyrimido[4,5h][1,6]naphthyridine-1,3,6-trione | Mycobacterium leprae | |
CD10929 | i.e. 5-[5-(2,4-difluorophenyl)furan-2-yl]-1-(2,4-difluorophenyl)sulfonylpyrazole | Mycobacterium leprae | |
CD12049 | i.e. N2-phenyl-5-(1,3-dibenzylhexahydropyrimidin-5-yl)-2H-1,2,3,4-tetraazole-2-carbox amide | Mycobacterium leprae | |
clofazimine | i.e. N-5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine | Mycobacterium leprae | |
dapsone | i.e. diaphenylsulfone | Mycobacterium leprae | |
DSSH00248 | i.e. N1,N2-di[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]phthalamide | Mycobacterium leprae | |
HTS01959 | i.e. N-(2-hydroxy-1,3-dioxo-2,3-dihydro-1H-inden-2-yl)-9-oxo-9H-fluorene-4carboxamide | Mycobacterium leprae | |
HTS08262 | i.e. [2-(2,3-dihydro-1-benzofuran-5-yl)-1,3-thiazol-4-yl] [4-(9H-fluoren-9-yl)piperazino] methanone | Mycobacterium leprae | |
HTS11201 | i.e. 7-[(3,4-dichlorophenyl)methyl]-1,3-dimethyl-8-[2-(2-oxoindol-3-yl)hydrazinyl]purine-2,6-dione | Mycobacterium leprae | |
HTS11989 | i.e. 1-[2-[3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl]-5-(4-pyridinyl)-1,3,4-oxadiazole-3(2H)-yl]-1-ethanone | Mycobacterium leprae | |
HTS12673 | i.e. 1-[3-(4-methoxyphenyl)-3,3a,4,5-tetrahydro-2H-benzo[g]indazol-2-yl]-2-{[5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl] sulfanyl}-1-ethanone | Mycobacterium leprae | |
NRB00567 | i.e. 1-(9,10-dioxoanthracen-1-yl)sulfanylanthracene-9,10-dione | Mycobacterium leprae | |
NRB04869 | i.e. 7-(3-nitrophenyl)-6H,7H,8H-chromeno[3',4':5,6]pyrano[3,2-c]chromene-6,8-dione | Mycobacterium leprae | |
PD00399 | i.e. 2-[[1-benzothiophen-3-ylmethyl-[(1,3-dioxoisoindol-2-yl)methyl]amino]methyl]isoindole-1,3-dione | Mycobacterium leprae | |
RF00088 | i.e. 2-(5,7-dimethyl-4-oxochromen-3-yl)benzo[g]quinolone-4-carboxylic acid | Mycobacterium leprae | |
rifampicin | i.e. (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(1E)-[(4-methylpiperazin-1-yl)imino]methyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl acetate | Mycobacterium leprae | |
RJC02308 | i.e. 2-isoquinolin-3-yl-2-(1-nitro-9,10-dioxoanthracen-2-yl)acetonitrile | Mycobacterium leprae |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + L-cysteine + tRNACys | Mycobacterium leprae | - |
AMP + diphosphate + L-cysteinyl-tRNACys | - |
? | |
ATP + L-cysteine + tRNACys | Mycobacterium leprae TN | - |
AMP + diphosphate + L-cysteinyl-tRNACys | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium leprae | P57990 | - |
- |
Mycobacterium leprae TN | P57990 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + L-cysteine + tRNACys | - |
Mycobacterium leprae | AMP + diphosphate + L-cysteinyl-tRNACys | - |
? | |
ATP + L-cysteine + tRNACys | - |
Mycobacterium leprae TN | AMP + diphosphate + L-cysteinyl-tRNACys | - |
? |
Synonyms | Comment | Organism |
---|---|---|
CysRS | - |
Mycobacterium leprae |
cysteinyl tRNA synthetase | - |
Mycobacterium leprae |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Mycobacterium leprae |